An evaluation of evidence for the carcinogenic activity of bisphenol A

Jemal, 2006, Cancer statistics, 2004, CA Cancer J Clin, 54, 8, 10.3322/canjclin.54.1.8 NTP: carcinogenesis bioassay of bisphenol A (CAS no. 80-05-7) in F344 rats and B6C3F1 mice (feed study). National Toxicology Program Technical Report 1982;215:1–116. Welshons, 2003, Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity, Environ Health Perspect, 111, 994, 10.1289/ehp.5494 vom Saal, 2005, An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment, Environ Health Perspect, 113, 926, 10.1289/ehp.7713 Vandenberg, 2006, The mammary gland response to estradiol: monotonic at the cellular level, non-monotonic at the tissue-level of organization, J Steroid Biochem Mol Biol, 101, 263, 10.1016/j.jsbmb.2006.06.028 Putz, 2001, Neonatal low- and high-dose exposure to estradiol benzoate in the male rat. I. effects on the prostate gland, Biol Reprod, 65, 1496, 10.1095/biolreprod65.5.1496 Lifsted, 1998, Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression, Int J Cancer, 77, 640, 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8 Rowse, 1998, Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis, Cancer Res, 58, 2675 DiGiovanni, 1992, Further genetic analyses of skin tumor promoter susceptibility using inbred and recombinant inbred mice, Carcinogenesis, 13, 525, 10.1093/carcin/13.4.525 Chan, 1981, Enhancement of mammary carcinogenesis by a high-fat diet in Fischer, Long-Evans, and Sprague–Dawley rats, Cancer Res, 41, 164 Shisa, 1985, Genetically determined susceptibility of Fischer 344 rats to propylnitrosourea-induced thymic lymphomas, Cancer Res, 45, 1483 Moore, 1988, Comparison of 7,12-dimethylbenz[a]anthracene metabolism and DNA binding in mammary epithelial cells from three rat strains with differing susceptibilities to mammary carcinogenesis, Carcinogenesis, 9, 2099, 10.1093/carcin/9.11.2099 Stanley, 2001, Delayed effects of tamoxifen in hepatocarcinogenesis-resistant Fischer 344 rats as compared with susceptible strains, Cancer Lett, 171, 27, 10.1016/S0304-3835(01)00564-X Hilakivi-Clarke, 2002, Dietary modulation of pregnancy estrogen levels and breast cancer risk among female rat offspring, Clin Cancer Res, 8, 3601 Holm, 2005, Global loss of imprinting leads to widespread tumorigenesis in adult mice, Cancer Cell, 8, 275, 10.1016/j.ccr.2005.09.007 Savabieasfahani M, Kannan K, Astapova O, Evans NP, Padmanabhan V. Developmental programming: differential effects of prenatal exposure to bisphenol-A or methoxychlor on reproductive function. Endocrinol 2006; epub. Ho, 2006, Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase Type 4 Variant 4, Cancer Res, 66, 5624, 10.1158/0008-5472.CAN-06-0516 Newbold, 2006, Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations, Endocrinology, 147, S11, 10.1210/en.2005-1164 Titus-Ernstoff, 2006, Mortality in women given diethylstilbestrol in pregnancy, Br J Cancer, 95, 107, 10.1038/sj.bjc.6603221 Titus-Ernstoff, 2001, Long term risk in women given diethylstilbestrol (DES) during pregnancy, Br J Cancer, 84, 126, 10.1054/bjoc.2000.1521 Colton, 1993, Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up, JAMA, 269, 2096, 10.1001/jama.269.16.2096 Palmer, 2006, Prenatal diethylstilbestrol exposure and risk of breast cancer, Cancer Epidemiol Biomark Prev, 15, 1509, 10.1158/1055-9965.EPI-06-0109 Herbst, 1971, Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women, N Engl J Med, 284, 878, 10.1056/NEJM197104222841604 Herbst, 1976, Prenatal exposure to stilbestrol. A prospective comparison of exposed female offspring with unexposed controls, N Engl J Med, 292, 334, 10.1056/NEJM197502132920704 Howdeshell, 2003, Bisphenol A is released from used polycarbonate animal cages into water at room temperature, Environ Health Perspect, 111, 1180, 10.1289/ehp.5993 Hunt, 2003, Bisphenol A exposure causes meiotic aneuploidy in the female mouse, Curr Biol, 13, 546, 10.1016/S0960-9822(03)00189-1 Durando, 2007, Prenatal bisphenol A exposure induces pre-neoplastic lesions in the mammary gland of Wistar rats, Environ Health Perspect, 115, 80, 10.1289/ehp.9282 Tyl, 2002, Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague–Dawley rats, Toxicol Sci, 68, 121, 10.1093/toxsci/68.1.121 Welshons, 2006, Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure, Endocrinology, 147, S56, 10.1210/en.2005-1159 Fisher, 1998, Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study, J Natl Cancer Inst, 90, 1371, 10.1093/jnci/90.18.1371 Fisher, 2005, Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study, J Natl Cancer Inst, 90, 1371, 10.1093/jnci/90.18.1371 Strohsnitter, 2001, Cancer risk in men exposed in utero to diethylstilbestrol, J Natl Cancer Inst, 93, 545, 10.1093/jnci/93.7.545 Boylan, 1983, Transplacental action of diethylstilbestrol on mammary carcinogenesis in female rats given one or two doses of 7,12-dimethylbenz(a)anthrcene, Cancer Res, 43, 4879 Rothschild, 1987, Transplacental effects of diethylstilbestrol on mammary development and tumorigenesis in female ACI rats, Cancer Res, 47, 4508 Modugno, 2001, Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk, Clin Cancer Res, 7, 3092 Leav, 1988, Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Nobel rats, J Natl Cancer Inst, 80, 1045, 10.1093/jnci/80.13.1045 Bosland, 1995, Induction of a high incidence of ductal prostate adenocarcinomas in NBL and Sprague Dawley rats treated with estradiol-17-β or dietylstilbestrol in combination with testosterone, Carcinogenesis, 16, 1311, 10.1093/carcin/16.6.1311 Fowler, 2000, Overexpression of aromatase leads to development of testicular Leydig cell tumors: an in vivo model for hormone-mediated testicular cancer, Am J Pathol, 156, 347, 10.1016/S0002-9440(10)64736-0 Bosland, 1996, Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models, Prog Clin Biol Res, 394, 309 Kuiper, 1998, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β, Endocrinology, 139, 4252, 10.1210/en.139.10.4252 Lemmen, 2004, In vivo imaging of activated estrogen receptors in utero by estrogens and bisphenol A, Environ Health Perspect, 112, 1544, 10.1289/ehp.7155 Recchia, 2004, Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha, Food Addit Contam, 21, 134, 10.1080/02652030310001641177 Kurosawa, 2002, The activity of bisphenol A depends on both the estrogen receptor subtype and the cell type, Endocr J, 49, 465, 10.1507/endocrj.49.465 Leung, 2006, Estrogen receptor (ER)-β isoforms: a key to understanding ER-β signaling, Proc Natl Acad Sci USA, 103, 13162, 10.1073/pnas.0605676103 Ashby, 1998, Utertrophic activity of bisphenol A in the immature rat, Environ Health Perspect, 106, 719, 10.1289/ehp.98106719 Tinwell, 2000, Uterotrophic activity of bisphenol A in the immature mouse, Regul Toxicol Pharmacol, 32, 118, 10.1006/rtph.2000.1412 Markey, 2001, The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A, Environ Health Perspect, 109, 55, 10.1289/ehp.0110955 Steinmetz, 1998, The xenoestrogen bisphenol A induces growth, differentiation, and c-fos gene expression in the female reproductive tract, Endocrinology, 139, 2741, 10.1210/en.139.6.2741 Coldham, 1997, Evaluation of a recombinant yeast cell estrogen screening assay, Environ Health Perspect, 105, 734, 10.1289/ehp.97105734 Nagel, 2001, Development of an ER action mouse for the study of estrogens, selective ER modulators (SERMs), and xenobiotics, Endocrinology, 142, 4721, 10.1210/en.142.11.4721 Yamada, 2002, Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester, Reprod Toxicol, 16, 735, 10.1016/S0890-6238(02)00051-5 Zalko, 2003, Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD1 mice, Environ Health Perspect, 111, 309, 10.1289/ehp.5603 Schonfelder, 2002, Parent bisphenol A accumulation in the human maternal-fetal-placental unit, Environ Health Perspect, 110, A703, 10.1289/ehp.021100703 Boylan, 1981, Prenatal exposure to diethylstilbestrol: ovarian-independent growth of mammary tumors induced by 7,12-dimethylbenz[a]anthracene, J Natl Cancer Inst, 66, 649 Boylan, 1979, Mammary tumorigenesis in the rat following prenatal exposure to diethylstilbestrol and postnatal treatment with 7,12-dimethylbenz[a]anthracene, J Toxicol Environ Health, 5, 1059, 10.1080/15287397909529814 Song, 2002, Endocrine disruptor bisphenol a induces orphan nuclear receptor Nur77 gene expression and steroidogenesis in mouse testicular Leydig cells, Endocrinology, 143, 2208, 10.1210/en.143.6.2208 Walsh, 2005, Estrogen receptor independent rapid non-genomic effects of environmental estrogens on [Ca2+] in human breast cancer cells, Mol Cell Endocrinol, 230, 23, 10.1016/j.mce.2004.11.006 Wetherill, 2005, Xenoestrogen action in prostate cancer: pleiotropic effects dependent on androgen receptor status, Cancer Res, 65, 54, 10.1158/0008-5472.54.65.1 Wetherill, 2002, The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells, Mol Cancer Ther, 1, 515 Wetherill, 2006, Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer, Mol Cancer Ther, 5, 3181, 10.1158/1535-7163.MCT-06-0272 Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Cairns, 1983, Step by step into carcinogenesis, Nature, 304, 582, 10.1038/304582a0 Barker, 2004, The developmental origins of adult disease, J Am Coll Nutr, 23, 588S, 10.1080/07315724.2004.10719428 Joyce, 1998, Genomic imprinting and cancer, Mol Pathol, 51, 185, 10.1136/mp.51.4.185 Soto, 2005, Emergentism as a default: cancer as a problem of tissue organization, J Biosci, 30, 103, 10.1007/BF02705155 Tennant, 1987, Predicition of chemical carcinogenicity in rodents from in vitro genetic toxicity assays, Science, 236, 933, 10.1126/science.3554512 Schrader, 2002, Mutagenicity of bisphenol A (4,4′-isopropylidenediphenol) in vitro: effects of nitrosylation, Teratog Carcinog Mutagen, 22, 425, 10.1002/tcm.10039 Schweikl, 1998, The mutagenic activity of unpolymerized resin monomers in Salmonella typhimurium and V79 cells, Mutat Res, 415, 119, 10.1016/S1383-5718(98)00067-9 Tsutsui, 1998, Bisphenol-A induces cellular transformation, aneuploidy and DNA adduct formation in cultured Syrian Hamster Embryo cells, Int J Cancer, 75, 290, 10.1002/(SICI)1097-0215(19980119)75:2<290::AID-IJC19>3.0.CO;2-H Can, 2005, Bisphenol-A induces cell cycle delay and alters centrosome and spindle microtubular organization in oocytes during meiosis, Mol Hum Reprod, 11, 389, 10.1093/molehr/gah179 Susiarjo, 2007, Bisphenol A exposure in utero disrupts early oogenesis in the mouse, PLoS Genet, 3, 63, 10.1371/journal.pgen.0030005 Sajiki, 1999, Sensitive method for the determination of bisphenol-A in serum using two systems of high-performance liquid chromatography, J Chromatogr B: Biomed Sci Appl, 736, 255, 10.1016/S0378-4347(99)00471-5 Inoue, 2000, Determination of bisphenol A in human serum by high-performance liquid chromatography with multi-electrode electrochemical detection, J Chromatogr B: Biomed Sci Appl, 749, 17, 10.1016/S0378-4347(00)00351-0 Dash, 2006, Bisphenol A: do recent studies of health effects among humans inform the long-standing debate?, Mutat Res, 613, 68, 10.1016/j.mrrev.2006.04.001 Takahashi, 2001, Mutagenicity of bisphenol A and its suppression by interferon-α in human RSa cells, Mutat Res, 490, 199, 10.1016/S1383-5718(00)00161-3 Atkinson, 1995, In vitro conversion of environmental estrogenic chemical bisphenol A to DNA binding metabolite(s), Biochem Biophys Res Commun, 210, 424, 10.1006/bbrc.1995.1678 Atkinson, 1995, In vivo DNA adduct formation by bisphenol A, Environ Mol Mutagen, 26, 60, 10.1002/em.2850260109 Iso, 2006, DNA damage caused by bisphenol A and estradiol through estrogenic activity, Biol Pharm Bull, 29, 206, 10.1248/bpb.29.206 Hilliard, 1998, Chromosomal aberrations in vitro related to cytotoxicity of nonmutagenic chemicals and metabolid poisons, Environ Mol Mutagen, 31, 316, 10.1002/(SICI)1098-2280(1998)31:4<316::AID-EM3>3.0.CO;2-G Galloway, 1998, DNA synthesis inhibition as an indirect mechanism of chromosome aberrations: comparison of DNA-reactive and non-DNA-reactive clastogens, Mutat Res, 400, 169, 10.1016/S0027-5107(98)00044-X Tsutsui, 2000, Mammalian cell transformation an aneuploidy induced by five bisphenols, Int J Cancer, 86, 151, 10.1002/(SICI)1097-0215(20000415)86:2<151::AID-IJC1>3.0.CO;2-0 Ochi, 1999, Induction of multiple microtubule-organizing centers, multipolar spindles and multipolar division in cultured V79 cells exposed to diethylstilbestrol, estradiol-17β and bisphenol A, Mutat Res, 431, 105, 10.1016/S0027-5107(99)00190-6 Fowden, 2004, Endocrine mechanisms of intrauterine programming, Reproduction, 127, 515, 10.1530/rep.1.00033 Zandi-Nejad, 2006, Adult hypertension and kidney disease: the role of fetal programming, Hypertension, 47, 502, 10.1161/01.HYP.0000198544.09909.1a Ismail-Beigi, 2006, Metabolic programming: fetal origins of obesity and metabolic syndrome in the adult, Am J Physiol Endocrinol Metab, 291, E439, 10.1152/ajpendo.00105.2006 Xita, 2006, Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies, JCEM, 91, 1660, 10.1210/jc.2005-2757 vom Saal, 1997, Prostate enlargement in mice due to fetal exposure to low doses of estradiol of diethylstilbestrol and opposite effects at high doses, Proc Natl Acad Sci USA, 94, 2056, 10.1073/pnas.94.5.2056 Markey, 2001, In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland, Biol Reprod, 65, 1215, 10.1093/biolreprod/65.4.1215 Munoz de Toro, 2005, Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice, Endocrinology, 146, 4138, 10.1210/en.2005-0340 Newbold, 1990, Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis, Cancer Res, 50, 7677 Timms, 2005, Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra, Proc Natl Acad Sci USA, 102, 7014, 10.1073/pnas.0502544102 Yoshino, 2002, Lack of significant alteration in the prostate or testis of F344 rat offspring after transplacental and lactational exposure to bisphenol A, J Toxicol Sci, 27, 433, 10.2131/jts.27.433 Ashby, 1999, Lack of effects for low dose levels of bisphenol A and diethylstilbestrol on the prostate gland of CF1 mice exposed in utero, Regul Toxicol Pharmacol, 30, 156, 10.1006/rtph.1999.1317 Ashby, 2001, Toward resolution of the divergent effects of estrogens on the prostate gland of CF-1 mice, Environ Health Perspect, 109, A109, 10.1289/ehp.109-a109 Milman, 2002, Evaluation of the adequacy of published studies of low-dose effects of bisphenol A on the rodent prostate for use in human risk assessment, Regul Toxicol Pharmacol, 35, 338, 10.1006/rtph.2002.1553 Maffini, 2006, Endocrine disruptors and reproductive health: the case for bisphenol-A, Mol Cell Endocrinol, 254/255, 179, 10.1016/j.mce.2006.04.033 vom Saal, 2005, The importance of appropriate controls, animal feed, and animal models in intrepreting results from low-dose studies of bisphenol A, Birth Defects Res A, 73, 140, 10.1002/bdra.20120 Rizzo, 2005, Prostate epithelial stem cells, Cell Prolif, 38, 363, 10.1111/j.1365-2184.2005.00356.x Ichihara, 2003, Lack of carcinogenic risk in the prostate with transplacental and lactational exposure to bisphenol A in rats, J Toxicol Sci, 28, 165, 10.2131/jts.28.165 Hovey, 2005, Effects of neonatal exposure to diethylstilbestrol, tamoxifen, and toremifene on the BALB/c mouse mammary gland, Biol Reprod, 72, 423, 10.1095/biolreprod.104.029769 Vandenberg, 2007, Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland, Endocrinology, 148, 116, 10.1210/en.2006-0561 Murray, 2007, Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure, Reprod Toxicol, 23, 383, 10.1016/j.reprotox.2006.10.002 Yoshida, 2004, Maternal exposure to low doses of bisphenol A has no effects on development of female reproductive tract and uterine carcinogenesis in Donryu rats, J Reprod Dev, 50, 349, 10.1262/jrd.50.349 Nagaoka, 1994, Sequential observation of spontaneous endometrial adenocarcinoma development in Donryu rats, Toxicol Pathol, 22, 261, 10.1177/019262339402200304 Yoshida, 2002, Induction of different types of uterine adenocarcinomas in Donryu rats due to neonatal exposure to high-dose p-t-octyl, Carcinogenesis, 23, 1745, 10.1093/carcin/23.10.1745 Post-menopausal oestrogen therapy. IARC Mongr Eval Carcinog Risks Hum 1992;72:399–530. Liehr, 2000, Is estradiol a genotoxic mutagenic carcinogen?, Endocr Rev, 21, 40, 10.1210/er.21.1.40 Melnick, 2002, Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review, Environ Health Perspect, 110, 427, 10.1289/ehp.02110427